Logo

Ex Lexis-Nexis Exec Heads Celera’s Product Develop’t

Dec 31, 1999
Premium

ROCKVILLE, Md.--James Peck, 36, who spent the last 10 years developing internal and end-user software applications for the Lexis-Nexis online research company has been appointed vice-president, product development at Celera Genomics. Peck will be responsible for defining Celera’s product strategy and for tailoring the company’s research information system to customers’ needs. He will initially focus on development of products for Celera’s target markets, including the pharmaceutical and agriculture industries.

Filed under

Informatics
Breaking News
The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.